Molecular heterogeneity in deficiency of complement protein C2 type I.
Deficiency of the complement protein C2 (C2D), one of the most common genetic deficiencies of the complement system, is associated with rheumatological disorders and increased susceptibility to infection. Two types of C2D have been recognized, each in the context of specific major histocompatibility complex (MHC) haplotypes; type I, a deletion, frameshift and premature stop codon resulting in absence of detectable C2 protein synthesis, and type II, missense mutations resulting in a block in secretion of C2 proteins. Analysis of C2 expression in a child with C2 deficiency, a MHC haplotype different from those associated with type I or II C2D, and recurrent infections revealed additional molecular heterogeneity among C2 deficient patients. No detectable C2 protein was synthesized in the child's fibroblasts under conditions supporting C2 synthesis and secretion in normals and the child's C2 mRNA was reduced to 42% of normal. Nucleotide sequencing of RT-PCR fibroblast mRNA and genomic DNA revealed a type I C2 deficiency (28 base-pair deletion) on one allele and a previously unrecognized two base-pair deletion in exon 2 on the other. Expression of the closely linked factor B gene was markedly decreased (Bf mRNA 25% of normal), though Bf was up-regulated appropriately by interferon-gamma and the flanking sequence containing the Bf promoter was normal in this C2-deficient patient. Moreover, the concentration of Bf protein was normal in the patient's plasma.
Wang
X
X
Department of Paediatrics, Washington University School of Medicine, St Louis, MO 63110, USA.
Circolo
A
A
Lokki
M L
ML
Shackelford
P G
PG
Wetsel
R A
RA
Colten
H R
HR
D016470:Bacteremia / Q000276:immunology*; D001483:Base Sequence; D015152:Blotting, Northern; D018929:Cell Culture Techniques; D002648:Child; D003175:Complement C2 / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics; D011415:Complement Factor B / Q000096:biosynthesis / Q000235:genetics; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D009894:Opportunistic Infections / Q000276:immunology*; D010375:Pedigree; D011008:Pneumococcal Infections / Q000276:immunology*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000235:genetics; D012008:Recurrence
D003175:Complement C2; D012333:RNA, Messenger; D011415:Complement Factor B